Mary E. Caldorera-Moore
Biomaterials · 2012
A researcher in the Science corpus: 1 paper; trusts 10 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Biomaterials — 14 citations into it
- Molecular Biology — 13 citations into it
- Biomedical Engineering — 10 citations into it
Whom Mary E. Caldorera-Moore trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Mary E. Caldorera-Moore's perspective
Ordered by how strongly the researchers Mary E. Caldorera-Moore trusts endorse each paper. Same corpus, a different order for every researcher.
- Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. (Journal of the American Chemical Society)
- Folate receptor-mediated drug targeting: from therapeutics to diagnostics. (Journal of Pharmacy and Science)
- The effect of particle design on cellular internalization pathways (Proceedings of the National Academy of Sciences of the United States of America)
- Nanoparticles in cancer therapy and diagnosis. (Advanced Drug Delivery Reviews)
- Nanoparticle therapeutics: an emerging treatment modality for cancer (Nature reviews. Drug discovery)
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles (Proceedings of the National Academy of Sciences of the United States of America)
- Cisplatin and platinum drugs at the molecular level. (Review). (Oncology Report)
- Targeted drug delivery via the folate receptor. (Advanced Drug Delivery Reviews)
- DNA and its associated processes as targets for cancer therapy (Nature Reviews. Cancer)
- Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. (Advanced Drug Delivery Reviews)